NUCYNTA® ER (tapentadol) extended-release tablets:
The first and only opioid proven to
treat both chronic low back pain and
the neuropathic pain associated with
diabetic peripheral neuropathy (DPN)
NUCYNTA ER, as an opioid, has the
risks of addiction, abuse and misuse,
which can lead to overdose and death
Not an actual patient.

THE COMPLEXITY OF
CHRONIC PAIN



Review common types of chronic pain.

LEARN MORE

CO-PAY SAVINGS
FOR ELIGIBLE PATIENTS



NUCYNTA ER offers confidence of access and low out‑of‑pocket costs for your patients.

LEARN MORE

WATCH A KOL DISCUSSION
ABOUT USING NUCYNTA ER
IN APPROPRIATE PATIENTS